"IMPROVEMENTS IN WORK PRODUCTIVITY WITH UP TO 104 WEEKS OF APREMILAST MONOTHERAPY: RESULTS FROM A PHASE 3B, RANDOMIZED, CONTROLLED STUDY IN BIOLOGIC-NAIVE SUBJECTS WITH ACTIVE PSORIATIC ARTHRITIS" by Philip J. Mease

Article

IMPROVEMENTS IN WORK PRODUCTIVITY WITH UP TO 104 WEEKS OF APREMILAST MONOTHERAPY: RESULTS FROM A PHASE 3B, RANDOMIZED, CONTROLLED STUDY IN BIOLOGIC-NAIVE SUBJECTS WITH ACTIVE PSORIATIC ARTHRITIS

Acta Dermato-venereologica (2018)

Philip J. Mease
Dafna D. Gladman
Eric K. Davenport
Xiaolei Zhou
Benoit Guerette
Lichen Teng
Satyin Kaura
Peter Nash

Link

Disciplines

Dermatology and
Medicine and Health Sciences

Publication Date

January 1, 2018

DOI

10.2340/00015555-2784

Citation Information

Philip J. Mease, Dafna D. Gladman, Eric K. Davenport, Xiaolei Zhou, et al.. "IMPROVEMENTS IN WORK PRODUCTIVITY WITH UP TO 104 WEEKS OF APREMILAST MONOTHERAPY: RESULTS FROM A PHASE 3B, RANDOMIZED, CONTROLLED STUDY IN BIOLOGIC-NAIVE SUBJECTS WITH ACTIVE PSORIATIC ARTHRITIS" Acta Dermato-venereologica Vol. 98 Iss. 1 (2018) p. 14 - 14
Available at: http://works.bepress.com/philip-mease/366/